Glucotrack, Inc. (GCTK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Glucotrack, Inc. on September 12, 2025. The filing discloses the entry into a material definitive agreement involving the issuance of a Convertible Promissory Note and references a previously disclosed Equity Line of Credit (ELOC).
Key Financial Metrics and Transaction Details
- Convertible Note Issuance: The Company issued a Convertible Promissory Note with a principal amount of $3,600,000 for a purchase price of $3,000,000.
- Original Issue Discount (OID): The Note carries an OID of $600,000 and bears no interest.
- Debt Structure: The Note is an unsecured obligation ranking equal with existing and future unsecured indebtedness.
- Maturity: Due on the 12-month anniversary of the Issue Date or upon the closing of a "Qualified Financing" (defined as a capital stock sale with gross proceeds of at least $5,000,000).
- Conversion Terms: Upon a Qualified Financing, the Note converts into equity securities at the financing price, subject to a floor price of $4.87 per share.
- Equity Line of Credit (ELOC): On September 11, 2025, the Company established an ELOC with Sixth Borough Capital Fund, LP, allowing for the sale of up to $20.0 million of Common Stock.
Material Changes and Repayment Obligations
The filing details a specific repayment mechanism linking the new Note to the ELOC proceeds:
- Pre-Stockholder Approval: The Company must apply 100% of net proceeds from ELOC sales to repay the Note until stockholder approval is obtained to issue shares in excess of the "Exchange Cap."
- Post-Stockholder Approval: Following approval, the Company must apply 50% of net ELOC proceeds to repay the Note.
- Prepayment: The Company may prepay the Note at any time without investor consent.
Outlook, Risks, and Contingencies
- Events of Default: The Note includes standard events of default, including bankruptcy and insolvency, which would allow the Investor to demand immediate repayment of all outstanding principal.
- Covenants: The Note does not contain affirmative or restrictive covenants.
- Regulatory Status: The Note was issued in a private placement to an accredited investor under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
- Financial Data: The filing text does not provide current revenue, profit, cash flow, or liquidity metrics beyond the specific transaction details.
Key Facts for Investor Verification
- Verify the Company's current cash position and ability to service the $3.6 million principal obligation if a Qualified Financing does not occur within 12 months.
- Confirm the status of the "Stockholder Approval" required to modify the 100% ELOC proceeds repayment requirement.
- Assess the dilution impact of the $4.87 floor price on the Note conversion relative to the current market price of GCTK common stock.
- Review the terms of the ELOC with Sixth Borough Capital Fund, LP, specifically the "Exchange Cap" and commission structures affecting net proceeds.